We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current BCART market cap is 26.97M. The company's latest EPS is EUR -0.7031 and P/E is -0.41.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 28.65M | 37.73M | 55.56M | 54.9M | 57.98M |
| Operating Income | -46.8M | -55.98M | -46.91M | -62.96M | -47.64M |
| Net Income | -48.15M | -64.07M | -62.93M | -71.47M | -65.38M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 139.39M | 268.32M | 210.52M | 142.48M | 114.28M |
| Total Liabilities | 52.03M | 183.84M | 173.69M | 176.38M | 144.56M |
| Total Equity | 87.35M | 84.48M | 36.82M | -33.9M | -30.28M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -41.99M | -54.25M | -39.27M | -65.72M | -44.86M |
| Investing | -5.82M | -5.5M | -4.01M | -3.75M | -5.43M |
| Financing | -1.51M | 175.02M | -11.52M | -1.2M | 22.46M |
| Market Cap | 26.97M |
| Price to Earnings Ratio | -0.41 |
| Price to Sales Ratio | 0.47 |
| Price to Cash Ratio | 1.08 |
| Price to Book Ratio | -0.89 |
| Dividend Yield | - |
| Shares Outstanding | 92.99M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -54.69% |
| 52 Week High | 0.645 |
| 52 Week Low | 0.285 |
| Spread (Intraday) | -0.25 (-500%) |
| Company Name | Biocartis Group NV |
| Address |
generaal de wittelaan mechelen, antwerp B - 2800 |
| Website | https://www.biocartis.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
